An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Moeller, Marcus J ^a,b,c   Soofi, Abdulsalam ^c   Sanden, Silja ^c   Floege, Jürgen ^b   Kriz, Wilhelm ^a   Holzman, Lawrence B ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CMV promoter; Cre; Kidney; loxP; Transgenic mouse

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL TISSUE; ARTICLE; CYTOMEGALOVIRUS; GENOTYPE; KIDNEY; LOXP SITE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TRANSGENE; TRANSGENIC MOUSE;

EID: 22344438715     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00332.2004     Document Type: Article

References (29)

1. Bugeon L, Danou A, Carpentier D, Langridge P, Syed N, and Dallman MJ. Inducible gene silencing in podocyles: a new tool for studying glomerular function. J Am Soc Nephrol 14: 786-791, 2003.
2. Fukushige S and Sauer B. Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci USA 89: 7905-7909, 1992.
3. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, and Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 9302-9306,. 1994.
4. Garrick D, Fiering S, Martin DI, and Whitelaw E. Repeat-induced gene silencing in mammals. Nat Genet 18: 56-59, 1998.
5. Gossen M and Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 36: 153-173, 2002.
6. Grieshammer U, Lewandoski M, Prevelte D, Oppenheim RW, and Martin GR. Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss. Dev Biol 197: 234-247, 1998.
7. Hanahan D. Transgenic mice as probes into complex systems. Science 246: 1265-1275, 1989.
8. Hoess R and Abremski K. Nucleic Acids and Molecular Biology. Berlin/Heidelberg: Springer Verlag, 1990.
9. Imai E, Akagi Y, Isaka Y, Ikawa M, Takenaka M, Hori M, and Okabe M. Glowing podocytes in living mouse: transgenic mouse carrying a podocyte-specific promoter. Exp Nephrol 7: 63-66, 1999.
10. Jaeniseh R. Transgenic animals. Science 240: 1468-1474, 1988.
11. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci USA 83: 2850-2854, 1986.
12. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH, Mulder KL, and Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6232-6236, 1992.
13. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755, 2001.
14. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, and Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98: 12283-12288, 2001.
15. Liu Q, Li MZ, Leibham D, Cortez D, and Elledge SJ. The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes. Curr Opin Biol 8: 1300-1309, 1998.
16. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, and Nagy A. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 208: 281-292, 1999.
17. Moeller MJ, Kovari IA, and Holzman LB. Evaluation of a new tool for exploring podocyte biology: mouse Nphsl 5′ flanking region drives LacZ expression in podocytes. J Am Soc Nephrol 11: 2306-2314, 2000.
18. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, and Holzman LB. Podocyte-specific expression of ere recombinase in transgenic mice. Genesis 35: 39-42, 2003.
19. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, and Holzman LB. Two gene fragments that direct podocyte-specific expression in transgenic mice. J Am Soc Nephrol 13: 1561-1567, 2002.
20. Moeller MJ, Soofi A, Braun GS, Li X, Watzl C, Kriz W, and Holzman LB. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J 23: 3769-3779, 2004.
21. Niwa H, Yamamura K, and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991.
22. Orban PC, Chui D, and Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6861-6865, 1992.
23. Ramirez-Solis R, Liu P, and Bradley A. Chromosome engineering in mice. Nature 378: 720-724, 1995.
24. Sauer B. Multiplex Cre/lox recombination permits selective site-specific DNA targeting to both a natural and an engineered site in the yeast genome. Nucleic Acids Res 24: 4608-4613, 1996.
25. Sauer B and Henderson N. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17: 147-161, 1989.
26. Sauer B, Whealy M, Robbins A, and Enquist L. Site-specific insertion of DNA into a pseudorabies virus vector. Proc Natl Acad Sci USA 84: 9108-9112, 1987.
27. Schmidt EV, Christoph G, Zeller R, and Leder P. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol 10: 4406-4411, 1990.
28. Wharram BL, Goyal M, Gillespie PJ, Wiggins JE, Kershaw DB, Holzman LB, Dysko RC, Saunders TL, Samuelson LC, and Wiggins RC. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest 106: 1281-1290, 2000.
29. Zhang Y, Wienands J, Zurn C, and Reth M. Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk. EMBO J 17: 7304-7310, 1998.